Abstract

AbstractThe alteration in protein conformation not only affects the performance of its biological functions, but also leads to a variety of protein‐mediated diseases. Developing a sensitive strategy for protein detection and monitoring its conformation changes is of great significance for the diagnosis and treatment of protein conformation diseases. Herein, a plasmon‐enhanced fluorescence (PEF) sensor is developed, based on an aggregation‐induced emission (AIE) molecule to monitor conformational changes in protein, using prion protein as a model. Three anthracene derivatives with AIE characteristics are synthesized and a water‐miscible sulfonate salt of 9,10‐bis(2‐(6‐sulfonaphthalen‐2‐yl)vinyl)anthracene (BSNVA) is selected to construct the PEF–AIE sensor. The sensor is nearly non‐emissive when it is mixed with cellular prion protein while emits fluorescence when mixed with disease‐associated prion protein (PrPSc). The kinetic process of conformational conversion can be monitored through the fluorescence changes of the PEF–AIE sensor. By right of the amplified fluorescence signal, this PEF–AIE sensor can achieve a detection limit 10 pM lower than the traditional AIE probe and exhibit a good performance in human serum sample. Furthermore, molecular docking simulations suggest that BSNVA tends to dock in the β‐sheet structure of PrP by hydrophobic interaction between BSNVA and the exposed hydrophobic residues.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call